Cancer cell procoagulants and their implications
SG Gordon - Hematology/oncology clinics of North America, 1992 - Elsevier
Cancer cells induce abnormal blood coagulation through a process that probably involves a
combination of increased activators and deficiencies of anticoagulants. The probable
participating factors (including tissue factor-factor VII and cancer procoagulant) and their role
in this process are discussed. The current theory on the role of coagulation in malignant
disease is also discussed.
combination of increased activators and deficiencies of anticoagulants. The probable
participating factors (including tissue factor-factor VII and cancer procoagulant) and their role
in this process are discussed. The current theory on the role of coagulation in malignant
disease is also discussed.